Cholangitis, Sclerosing
Cholangitis, Sclerosing
Explore linked clinical trials. Standard reference: MESH:M002337145 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 2 | 2026-10-09 | NCT07341282 | |
| Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND) | Cholangitis, Sclerosing, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Abnormalities, Digestive System Diseases, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, bile duct disorder, biliary atresia, biliary tract disorder, cholangitis, skin disorder | Active, not recruiting | Phase 3 | 2026-10-06 | NCT06553768 | |
| A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitis | Recruiting | Phase 3 | 2026-10-01 | NCT07387549 | |
| A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitis | Active, not recruiting | Phase 2 | 2026-10-01 | NCT05627362 | |
| Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus | Cholangitis, Sclerosing, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis, primary sclerosing cholangitis | Not yet recruiting | Phase 2 | 2026-09-28 | NCT07843420 | |
| FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, primary sclerosing cholangitis | Recruiting | Phase 2 | 2026-09-24 | NCT06286709 | |
| Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, liver disorder, primary sclerosing cholangitis | Recruiting | Not stated | 2026-09-22 | NCT04685200 | |
| Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Not yet recruiting | Phase 2 | 2026-09-10 | NCT07646223 | |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) | Cholangitis, Sclerosing, Digestive System Diseases, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, primary sclerosing cholangitis, skin disorder | Active, not recruiting | Phase 2 | 2026-08-26 | NCT04663308 | |
| A-LiNK: Improving Outcomes in Autoimmune Liver Disease | Cholangitis, Sclerosing, Digestive System Diseases, Hepatic Insufficiency, Hepatitis, Chronic, autoimmune disease, autoimmune hepatitis, bile duct disorder, biliary tract disorder, cholangitis, chronic liver failure, hepatitis, immune system disorder, liver disorder, liver failure, primary sclerosing cholangitis | Recruiting | Not stated | 2026-08-19 | NCT05750498 | |
| MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease | Cholangitis, Sclerosing, Digestive System Diseases, Hepatitis, Chronic, autoimmune disease, autoimmune hepatitis, bile duct disorder, biliary tract disorder, cholangitis, hepatitis, immune system disorder, liver disorder, primary sclerosing cholangitis | Recruiting | Not stated | 2026-08-19 | NCT03178630 | |
| MRI Based Biomarkers in Pediatric Autoimmune Liver Disease | Cholangitis, Sclerosing, Digestive System Diseases, Hepatitis, Chronic, autoimmune disease, autoimmune hepatitis, bile duct disorder, biliary tract disorder, cholangitis, hepatitis, immune system disorder, liver disorder, primary sclerosing cholangitis | Recruiting | Not stated | 2026-08-19 | NCT03175471 | |
| LEOPARD Prospective Validation Cohort 1 | Cholangitis, Sclerosing, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis, primary sclerosing cholangitis | Recruiting | Not stated | 2026-07-29 | NCT06723275 | |
| LEOPARD Training and Validation Data Collection Study | Cholangitis, Sclerosing, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis, primary sclerosing cholangitis | Recruiting | Not stated | 2026-07-29 | NCT06675604 | |
| Detoxification of the Liver In PSC (Dolphin) | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitis | Recruiting | Phase 2 | 2026-07-21 | NCT05835505 | |
| Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitis | Recruiting | Phase 2 | 2026-07-17 | NCT06905054 | |
| Primary Sclerosing Cholangitis in Children | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, liver disorder, primary sclerosing cholangitis | Recruiting | Not stated | 2026-07-14 | NCT04181138 | |
| The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching | Cholangitis, Sclerosing, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Fibrosis, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Diseases, Eczematous, Skin Manifestations, Skin and Connective Tissue Diseases, atopic eczema, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, cirrhosis of liver, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, intrahepatic cholestasis, liver disorder, primary biliary cholangitis, skin disorder | Not yet recruiting | Phase 2 | 2026-07-01 | NCT07678645 | |
| Biodegradable Stents in Primary Sclerosing Cholangitis | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis | Recruiting | Not applicable | 2026-05-29 | NCT07607353 | |
| Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitis | Recruiting | Early phase 1 | 2026-05-20 | NCT06197308 | |
| Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome | Abdominal Abscess, Cholangitis, Sclerosing, Digestive System Diseases, Fibrosis, Hepatitis, Chronic, Infections, Liver Abscess, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Suppuration, abscess, autoimmune disease, autoimmune hepatitis, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, cirrhosis of liver, fatty liver disease, hepatitis, immune system disorder, intrahepatic cholestasis, liver disorder, metabolic dysfunction-associated steatotic liver disease, primary biliary cholangitis, primary sclerosing cholangitis | Recruiting | Not stated | 2026-03-20 | NCT06519162 | |
| Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Not yet recruiting | Phase 2 | 2026-03-17 | NCT07477782 | |
| CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis) | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitis | Active, not recruiting | Phase 2 | 2026-03-13 | NCT05896137 | |
| A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC) | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitis | Recruiting | Phase 1 | 2026-03-05 | NCT07229911 | |
| Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, primary sclerosing cholangitis | Recruiting | Early phase 1 | 2026-02-27 | NCT05912387 |